Molecular Biology Reports Генетика

Whole-exome sequencing identifies known and potential candidate genes in primary amenorrhea with premature ovarian insufficiency

Kazeminia, Mahsa, Rahbarian, Nahid, Amiri-Yekta, Amir, Rahimian, Mouness, Almadani, Navid, Mashayekhi, Mehri, Boroujeni, Parnaz Borjian, Ahmadpour, Kosar, Bazrgar, Masood
Springer Nature · 2026-11-16 · DOI 10.1007/s11033-026-13166-y

Аннотация

Background Premature ovarian insufficiency (POI), characterized by early depletion of the ovarian reserve, affects 3.5–3.7% of women and is a major cause of infertility. It presents as primary or secondary amenorrhea with hypergonadotropic hypogonadism. Genetic factors play a major role, particularly in primary amenorrhea. Methods and Results Whole-exome sequencing (WES) was performed in seven women with idiopathic POI and primary amenorrhea. Variants were analyzed using two parallel approaches: targeted analysis of 1,163 established and candidate POI genes and an untargeted exome-wide search for additional candidate genes. Selected variants were interpreted according to American College of Medical Genetics and Genomics (ACMG) guidelines and validated by Sanger sequencing. A likely molecular diagnosis was established in 28.6% (2/7) of cases: a homozygous pathogenic variant in LARS2 , an established POI gene, and a homozygous truncating ZSWIM7 variant, in an emerging POI gene, in a patient who also carried a heterozygous likely pathogenic variant in POLG . The ZSWIM7 variant was considered the most plausible explanation for the phenotype. Additional variants of uncertain significance (VUS) were identified in previously reported POI-associated genes ( ERCC6 , HSF2BP , SOHLH2 , and RYR3 ), while rare variants were identified in preliminary candidate genes ( ZP4 , ACADVL , CSH1 , and RGS22 ). Conclusions These findings demonstrate the value of WES for the molecular diagnosis of POI, facilitating earlier diagnosis and improved genetic counseling. Further functional and segregation studies are required to establish the pathogenicity of the identified VUS and preliminary candidate genes.

Читать у издателя →